PRINCETON - PDS Biotechnology Corporation (NASDAQ:PDSB) has confirmed plans to commence its VERSATILE-003 Phase 3 clinical trial for a promising cancer immunotherapy within the first quarter of 2025.

Heartland Dental, Aspen Dental and PDS Health are the three largest DSOs and MSOs in the dental industry. Here is how the three organizations stack up based on the number of practices in their network ...

Foundation made significant progress in 2024, expanding access to essential oral health care and reaching more patients and communities than ever before. From expanding care for patients with special ...

Blue Trust Inc. increased its stake in shares of Precision Drilling Co. (NYSE:PDS – Free Report) (TSE:PD) by 64.7% in the ...

Robbinsville boys basketball advances past Princeton Day in the CVC Tournament with a clutch second half to set up a quarterfinal game at WW-P North ...

Despite humanity's scientific achievements and globalized economy, malnutrition remains a global issue. The United Nations estimated that 2.33 billion people experienced moderate or severe food ...

Companies in the Energy sector have received a lot of coverage today as analysts weigh in on Pyxis Tankers (PXS – Research Report), Strike ...

South Africa’s pioneering role in proximity detection systems (PDS) has created opportunities for Booyco Electronics to ...

WASHINGTON – The U.S. Navy has recently awarded a series of contracts, under Program Executive Office, Unmanned and Small ...

Discover the impressive growth and innovation of PDS Health in 2024, including opening 63 new practices and providing over $26 million in donated services.

Precision Drilling downgraded at TD Cowen, saying the proposed 10% tariff likely will hurt Canadian drilling and completion activity in conventional heavy oil plays like the Clearwater.

The Philippine Stock Exchange Inc. (PSE) has closed another share purchase deal with one of the shareholders of the ...